Shearman & Sterling advised EMZ Partners (EMZ) on the financing of the acquisition of a majority stake in FotoFinder Systems GmbH (FotoFinder), a leading provider of skin visualization technology for early skin cancer detection and aesthetics.

Founded in 1991, FotoFinder offers products and services to dermatologists, dermatology clinics, hospitals, screening centers and research institutes. The solutions sold combine proprietary AI-based software with industry-leading Automated Total Body Mapping capabilities as well as video dermoscopy devices, forming integrated system solutions for skin imaging.

EMZ is a leading European investment firm that acts as a partner for medium-sized companies and their respective management teams. Its activities focus on investments with a clear intention to operate and support founders, family shareholders, and managers. EMZ is majority-owned by its own employees and has a base of European institutional investors. The current fund has a volume of more than €1.0 billion and its investment size ranges from €10 to €150 million.